Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.
Good Sign:
Weihai Baihe Biology Technological Co has a Altman Z2-Score of 13.26, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.
The zones of discrimination were as such:
When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.
Weihai Baihe Biology Technological Co (SHSE:603102) Altman Z2-Score Explanation
The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Weihai Baihe Biology Technological Co Altman Z2-Score Chart
SHSE:603102 vs KHC, GIS: Altman Z2-Score Comparison
For the Packaged Foods subindustry, Weihai Baihe Biology Technological Co's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Weihai Baihe Biology Technological Co Altman Z2-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Weihai Baihe Biology Technological Co's Altman Z2-Score distribution charts can be found below:
* The bar in red indicates where Weihai Baihe Biology Technological Co's Altman Z2-Score falls into.
Weihai Baihe Biology Technological Co Altman Z2-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.
Weihai Baihe Biology Technological Co (SHSE:603102) has a Altman Z2-Score of 13.26 as of Jul. 27, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Weihai Baihe Biology Technological Co and its competitors. This is near median its historical median of 13.26. Over the past decade, Weihai Baihe Biology Technological Co's Altman Z2-Score has ranged from 5.18 to 15.81. According to the industry distribution chart, Weihai Baihe Biology Technological Co ranks #105 out of 1959 companies in the Consumer Packaged Goods industry, placing it in the top 5.4%.
Is Weihai Baihe Biology Technological Co's Altman Z2-Score too high?
Weihai Baihe Biology Technological Co's current Altman Z2-Score of 13.26 is near median its 10-year median of 13.26. Over the past 10 years, this metric has ranged from a low of 5.18 to a high of 15.81. The Consumer Packaged Goods industry median Altman Z2-Score is 3.73. Weihai Baihe Biology Technological Co's value of 13.26 is 255.5% above this industry median. Based on the distribution chart, Weihai Baihe Biology Technological Co ranks #105 out of 1959 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Weihai Baihe Biology Technological Co has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Weihai Baihe Biology Technological Co's Altman Z2-Score compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Weihai Baihe Biology Technological Co ranks #105 out of 1959 companies for Altman Z2-Score. This places Weihai Baihe Biology Technological Co in the top 5% of its industry — outperforming the majority of peers. The industry median Altman Z2-Score is 3.73. Weihai Baihe Biology Technological Co's value of 13.26 is 255.5% above this benchmark. Historically, Weihai Baihe Biology Technological Co's own Altman Z2-Score has ranged from 5.18 to 15.81 over the past decade. While the company's 10-year median is 13.26 vs. the industry median of 3.73, Weihai Baihe Biology Technological Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Consumer Packaged Goods company?
The median Altman Z2-Score among Consumer Packaged Goods companies is 3.73, based on 1,959 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Weihai Baihe Biology Technological Co's current Altman Z2-Score of 13.26 is 255.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Weihai Baihe Biology Technological Co and its competitors. For the Consumer Packaged Goods industry, the median Altman Z2-Score is 3.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Weihai Baihe Biology Technological Co's current Altman Z2-Score is 13.26, which is near median its own 10-year median of 13.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Weihai Baihe Biology Technological Co stock overvalued right now?
Based on GuruFocus' analysis, Weihai Baihe Biology Technological Co (SHSE:603102) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥48.82, compared to a current price of ¥31.30 — trading 35.9% below its estimated fair value. The current Altman Z2-Score is 13.26, which is near median its 10-year median of 13.26 and 255.5% above the Consumer Packaged Goods industry median of 3.73. Weihai Baihe Biology Technological Co's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Weihai Baihe Biology Technological Co (SHSE:603102), the current Altman Z2-Score is 13.26 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Weihai Baihe Biology Technological Co (SHSE:603102) Overvalued in 2026?
Based on GuruFocus' analysis, Weihai Baihe Biology Technological Co stock appears to be undervalued.
The current stock price of ¥31.30 is trading 35.9% below its estimated GF Value™ of ¥48.82.
GuruFocus considers Weihai Baihe Biology Technological Co to be Significantly Undervalued.
Key valuation signals for SHSE:603102:
Altman Z2-Score: 13.26 (near median its 10-year median of 13.26)
GF Value™: ¥48.82 vs. price of ¥31.30 (35.9% below fair value)
Industry Position: 255.5% above the Consumer Packaged Goods median (#105 of 1959)
No single metric tells the full story. See the SHSE:603102 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Weihai Baihe Biology Technological Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603102 has been successfully added to your 
